|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.70 INR | +3.53% |
|
-0.04% | -15.94% |
| 09/07 | Camlin Fine Sciences Ownership in Vinpai Tops 95% After Cash Tender Offer | MT |
| 06/07 | Camlin Fine Sciences Limited completed the acquisition o 11.00049 % stake in Vinpai SAS for ?1.8 million. | CI |
Company Valuation: Camlin Fine Sciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21,899 | 20,006 | 14,946 | 31,552 | 18,623 | 23,954 | - |
| Change | - | -8.65% | -25.29% | 111.1% | -40.98% | 28.63% | - |
| Enterprise Value (EV) | 21,899 | 20,006 | 14,946 | 31,552 | 18,623 | 23,954 | 23,954 |
| Change | - | -8.65% | -25.29% | 111.1% | -40.98% | 28.63% | 0% |
| P/E | 30.6x | 37.3x | -16x | -20.9x | 67.3x | 31.2x | 15.3x |
| PBR | - | 2.44x | 1.73x | - | 1.86x | 2.14x | 1.97x |
| PEG | - | -1.5x | 0x | -0.5x | -1x | 0x | 0x |
| Capitalization / Revenue | 1.55x | 1.19x | 0.93x | - | 1.08x | 1.12x | 1.01x |
| EV / Revenue | 0x | 0x | 0x | - | 0x | 1.12x | 1.01x |
| EV / EBITDA | 0x | 0x | 0x | - | 0x | 9.52x | 7.22x |
| EV / EBIT | 0x | 0x | -0x | - | 0x | 13.9x | 9.86x |
| EV / FCF | -0x | -0x | 0x | -0x | 0x | 292x | 14x |
| FCF Yield | -3.12% | -4.67% | 5.25% | -0.5% | 1.32% | 0.34% | 7.14% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | 4.56 | 3.41 | -5.58 | -8.03 | 1.44 | 4 | 8.15 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 14,121 | 16,816 | 16,131 | - | 17,233 | 21,331 | 23,616 |
| EBITDA 1 | 1,528 | 2,053 | 739.2 | - | 1,069 | 2,517 | 3,318 |
| EBIT 1 | 968.4 | 1,428 | -46.91 | - | 359.6 | 1,726 | 2,430 |
| Net income 1 | 606.8 | 521.1 | -927.5 | - | 276.3 | 765 | 1,568 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 139.50 | 127.35 | 89.25 | 167.90 | 96.95 | 124.70 | 124.70 |
| Nbr of stocks (in thousands) | 1,56,984 | 1,57,093 | 1,67,465 | 1,87,921 | 1,92,087 | 1,92,092 | - |
| Announcement Date | 19/05/22 | 22/05/23 | 20/05/24 | 23/05/25 | 26/05/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 30.11x | - | - | - | 24Cr | ||
| 33.76x | 4.79x | 19.27x | 1.11% | 7.41TCr | ||
| 28.48x | 4.34x | 18.62x | 2.33% | 3.59TCr | ||
| 21.39x | 2.6x | 13.41x | 2.49% | 3.02TCr | ||
| 15.42x | 1.48x | 8.98x | 2.04% | 2.65TCr | ||
| 36.5x | 8.95x | 27.22x | 2.51% | 2.25TCr | ||
| 10.54x | 2.76x | 5.77x | 3.72% | 1.98TCr | ||
| 26.53x | 2.76x | 11.26x | 1.61% | 1.86TCr | ||
| 10.94x | 2.34x | 5.04x | 1.39% | 1.38TCr | ||
| 22.17x | 2.65x | 12.21x | 1.54% | 1.33TCr | ||
| Average | 23.58x | 3.63x | 13.53x | 2.08% | 2.55TCr | |
| Weighted average by Cap. | 25.71x | 3.94x | 15.34x | 1.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CAMLINFINE Stock
- Valuation Camlin Fine Sciences Limited
Select your edition
All financial news and data tailored to specific country editions
















